Apera Asset Management (“Apera”), a pan-European private debt investor in the midmarket space, is pleased to announce that it has arranged debt facilities to support the acquisition of Lensys, a French fast-growing anaesthesia software developer, by Bow Medical, a portfolio company of Extens specialised in clinic information software.
Founded in 1999, Bow Medical is a French developer and publisher of clinic information software for hospitals and clinics, focusing on critical care (e.g., anaesthesia, ICUs and maternity care). The company has experienced strong growth on the back of its comprehensive offering and the recognised best-in-class performance of its softwares.
Valentine Deramecourt, Director at Extens, said: “We have very much enjoyed working with the Apera investment team, their flexibility and speed was crucial to closing this transaction.”
Pierre Touton, CEO of Bow Medical, has declared: “Apera’s flexible capital will support Bow Medical’s strong growth plans and international ambitions.”
Salim Lemseffer, Principal at Apera Asset Management, added: “Bow Medical is well positioned to capture the strong underlying trends in the European critical care software market. We are pleased to partner with Extens in supporting the growth of the business and look forward to working with them and Bow Medical in future developments.”
You can download the Press Release here.
Apera Asset Management LLP is authorised and regulated by the Financial Conduct Authority (FRN: 771080).
Apera Asset Management LLP is incorporated in the UK and the registered office is at 33 Cavendish Square, London, W1G 0PW, United Kingdom.
The services of Apera Asset Management LLP are only available to professional clients and eligible counterparties. They are not available to retail clients.
Copyright Apera Asset Management ©2025. All rights reserved.
